Table 2 Development of person-time with viral suppression and viremia among all diagnosed PLHIV in the cohorts, including ART-naïve and treated person-time between 1999 and 2018 based on our longitudinal model
All diagnosed people living with HIV | ||||||||
|---|---|---|---|---|---|---|---|---|
Year | Viral suppression (< 50) | 50 - < 200 | 200 - < 500 | 500 - < 1000 | 1000 - < 10,000 | 10,000 - < 100,000 | 100,000 - < 1.000000 | > 1000,000 |
1999 | 22.2 | 9.1 | 7.4 | 4.8 | 18.2 | 24.5 | 12.8 | 0.8 |
2000 | 39.0 | 8.4 | 5.5 | 3.8 | 13.8 | 20.7 | 8.4 | 0.3 |
2001 | 45.0 | 7.2 | 4.3 | 3.2 | 13.8 | 18.2 | 7.9 | 0.3 |
2002 | 46.7 | 6.7 | 4.1 | 2.9 | 12.6 | 19.2 | 7.6 | 0.2 |
2003 | 50.8 | 6.0 | 3.2 | 2.2 | 11.3 | 17.9 | 8.2 | 0.4 |
2004 | 50.6 | 6.4 | 3.1 | 2.2 | 10.7 | 18.7 | 8.1 | 0.3 |
2005 | 52.8 | 6.3 | 3.0 | 2.3 | 10.6 | 17.9 | 6.9 | 0.3 |
2006 | 55.5 | 6.4 | 3.0 | 2.1 | 10.7 | 16.7 | 5.3 | 0.3 |
2007 | 58.1 | 6.7 | 2.7 | 2.0 | 9.7 | 15.9 | 4.5 | 0.3 |
2008 | 62.0 | 6.5 | 2.6 | 1.8 | 9.0 | 13.3 | 4.6 | 0.3 |
2009 | 65.3 | 6.2 | 2.2 | 1.6 | 7.7 | 12.8 | 4.1 | 0.3 |
2010 | 68.7 | 6.5 | 2.2 | 1.5 | 6.5 | 11.2 | 3.2 | 0.2 |
2011 | 73.2 | 6.6 | 2.0 | 1.3 | 5.4 | 8.7 | 2.6 | 0.2 |
2012 | 75.6 | 6.2 | 2.0 | 1.2 | 5.0 | 7.5 | 2.3 | 0.2 |
2013 | 78.6 | 5.8 | 1.8 | 1.1 | 4.2 | 6.3 | 2.1 | 0.2 |
2014 | 83.6 | 4.8 | 1.3 | 0.9 | 3.3 | 4.9 | 1.1 | 0.1 |
2015 a | 86.7 a | 3.8 a | 1.1 | 0.8 | 2.8 | 3.8 | 0.9 | 0.1 |
2016 | 88.3 | 4.4 | 1.0 | 0.7 | 2.3 | 2.4 | 0.9 | 0.1 |
2017 b | 91.3 b | 3.7 | 0.8 | 0.5 | 1.5 | 1.5 | 0.6 | 0.1 |
2018 | 92.3 | 3.3 | 0.8 | 0.4 | 1.2 | 1.2 | 0.6 | 0.1 |